ADAR1 CAPITAL MANAGEMENT, LLC purchased 1.0% of their position (9.57K shares) of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $12.7K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 10/15/2026ACC: 0001940272-26-000025
10% Owner
Since May 2026
+9.57K
Net shares
Net buyer
$12.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
9.57K acquired
Non-Derivative Transactions3
Common Shares
Indirect
Shares
+564.00
Price / share
$1.33
Trade value
$750.12
% of position
0.1%
10/13/2026
945.92K→946.49K
Common Shares
Indirect
Shares
+8.02K
Price / share
$1.33
Trade value
$10.67K
% of position
0.8%
10/14/2026
946.49K→954.51K
Common Shares
Indirect
Shares
+984.00
Price / share
$1.32
Trade value
$1.30K
% of position
0.1%
10/15/2026
954.51K→955.49K
Total
Net shares
+9.57K
Net value
$12.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 10/13/2026 | P · Purchase | +564.00 | $1.33 | $750.12 | 0.1% | 945.92K | 946.49K |
| Common Shares Indirect | 10/14/2026 | P · Purchase | +8.02K | $1.33 | $10.67K | 0.8% | 946.49K | 954.51K |
| Common Shares Indirect | 10/15/2026 | P · Purchase | +984.00 | $1.32 | $1.30K | 0.1% | 954.51K | 955.49K |
| Total | +9.57K | $12.72K | ||||||
Derivative Transactions0
No derivative transactions reported